SCHEMBL4906842

SCHEMBL4906842

COC(=O)c1cc(S(=O)(=O)NCCc2coc(-c3ccc(C(F)(F)F)cc3)n2)ccc1C

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
HTT P42858 2/20 0.45
KDM4E B2RXH2 2/20 0.45
POLB P06746 1/20 0.45
PPARG P37231 2/20 0.44
PPARA Q07869 2/20 0.44
GAA P10253 1/20 0.39
TP53 P04637 3/20 0.38
PKM P14618 1/20 0.37
MAPK1 P28482 1/20 0.37
MAPT P10636 3/20 0.37
MMP1 P03956 1/20 0.37
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
KDM1A O60341 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906505 0.93 LMNA (0.46) LMNASMN1; SMN2HTTKDM4EPOLB
SCHEMBL4900708 0.92 PPARG (0.41) LMNASMN1; SMN2HTTKDM4EPOLB
SCHEMBL4903863 0.91 PPARG (0.42) LMNASMN1; SMN2HTTKDM4EPOLB
SCHEMBL4903596 0.91 PPARG (0.50) LMNASMN1; SMN2HTTKDM4EPOLB
SCHEMBL4900873 0.85 PPARG (0.52) LMNASMN1; SMN2HTTKDM4EPOLB
SCHEMBL4911898 0.85 PPARG (0.44) LMNASMN1; SMN2HTTKDM4EPOLB
SCHEMBL4897574 0.85 LMNA (0.47) LMNASMN1; SMN2HTTKDM4EPOLB
SCHEMBL4906000 0.83 PPARG (0.41) LMNASMN1; SMN2HTTKDM4EPOLB
SCHEMBL4895720 0.83 PPARG (0.40) LMNASMN1; SMN2HTTKDM4EPOLB
SCHEMBL4902600 0.82 LMNA (0.64) LMNASMN1; SMN2HTTKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD LMNA 317/4885SMN1; SMN2 3271/4885HTT 711/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885SMN1; SMN2 3404/4885HTT 696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.